Genolution Inc. (KOSDAQ:225220)

Market Cap	38.93B
Revenue (ttm)	8.77B
Net Income (ttm)	-10.26B
Shares Out	18.07M
EPS (ttm)	-568.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	114,707
Average Volume	63,944
Open	2,155.00
Previous Close	2,155.00
Day's Range	2,155.00 - 2,300.00
52-Week Range	1,980.00 - 3,065.00
Beta	-0.01
RSI	35.83
Earnings Date	Nov 14, 2025

About Genolution

Genolution Inc. manufactures and sells IVD products in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and dsRNA research for the prevention of breeding and extermination. The company offers Nextractor, an automatic extraction system for isolation of DNA or RNA from various samples; and FFPE, whole blood, buccal swab, RV, TB/NTM, STD, HPV, HBV, and CMV/EBV extraction kits, as well as rice, plant, and cell extraction kits. It also provides siRNA/shRNA sy...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2006
• Employees: 75
• Stock Exchange: KOSDAQ
• Ticker Symbol: 225220

Financial Performance

In 2024, Genolution's revenue was 7.14 billion, a decrease of -26.90% compared to the previous year's 9.76 billion. Losses were -6.83 billion, 23.8% more than in 2023.